62 related articles for article (PubMed ID: 25347557)
1. Cytotoxic effect of fluvastatin on MCF-7 cells possibly through a reduction of the mRNA expression levels of SGK1 and CAV1.
Salis O; Bedir A; Gulten S; Okuyucu A; Kulcu C; Alacam H
Cancer Biother Radiopharm; 2014 Nov; 29(9):368-75. PubMed ID: 25347557
[TBL] [Abstract][Full Text] [Related]
2. The relationship between anticancer effect of metformin and the transcriptional regulation of certain genes (CHOP, CAV-1, HO-1, SGK-1 and Par-4) on MCF-7 cell line.
Salis O; Bedir A; Ozdemir T; Okuyucu A; Alacam H
Eur Rev Med Pharmacol Sci; 2014 Jun; 18(11):1602-9. PubMed ID: 24943970
[TBL] [Abstract][Full Text] [Related]
3. Antimetastatic effect of fluvastatin on breast and hepatocellular carcinoma cells in relation to SGK1 and NDRG1 genes.
Salis O; Okuyucu A; Bedir A; Gör U; Kulcu C; Yenen E; Kılıç N
Tumour Biol; 2016 Mar; 37(3):3017-24. PubMed ID: 26419593
[TBL] [Abstract][Full Text] [Related]
4. Fluvastatin inhibits the expression of fibronectin in human peritoneal mesothelial cells induced by high-glucose peritoneal dialysis solution via SGK1 pathway.
Zhang L; Liu J; Liu Y; Xu Y; Zhao X; Qian J; Sun B; Xing C
Clin Exp Nephrol; 2015 Jun; 19(3):336-42. PubMed ID: 24942605
[TBL] [Abstract][Full Text] [Related]
5. Sterol regulatory element binding protein-mediated effect of fluvastatin on cytosolic 3-hydroxy-3-methylglutaryl-coenzyme A synthase transcription.
Mascaró C; Ortiz JA; Ramos MM; Haro D; Hegardt FG
Arch Biochem Biophys; 2000 Feb; 374(2):286-92. PubMed ID: 10666309
[TBL] [Abstract][Full Text] [Related]
6. Statin-induced breast cancer cell death: role of inducible nitric oxide and arginase-dependent pathways.
Kotamraju S; Williams CL; Kalyanaraman B
Cancer Res; 2007 Aug; 67(15):7386-94. PubMed ID: 17671209
[TBL] [Abstract][Full Text] [Related]
7. Expression of serum and glucocorticoid-inducible kinase1 in diabetic rats and its modulation by fluvastatin.
Wang X; Luo C; Liu J; Zhang C; Wang Y; Zhu Z
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(6):651-4. PubMed ID: 16696316
[TBL] [Abstract][Full Text] [Related]
8. The anticancer effects of desferrioxamine on human breast adenocarcinoma and hepatocellular carcinoma cells.
Salis O; Bedir A; Kilinc V; Alacam H; Gulten S; Okuyucu A
Cancer Biomark; 2014; 14(6):419-26. PubMed ID: 25335733
[TBL] [Abstract][Full Text] [Related]
9. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of Na+/Ca2+ exchanger by fluvastatin in rat cardiomyoblast H9c2 cells: involvement of RhoB in Na+/Ca2+ exchanger mRNA stability.
Maeda S; Matsuoka I; Iwamoto T; Kurose H; Kimura J
Mol Pharmacol; 2005 Aug; 68(2):414-20. PubMed ID: 15879517
[TBL] [Abstract][Full Text] [Related]
11. Identifying molecular features that distinguish fluvastatin-sensitive breast tumor cells.
Goard CA; Chan-Seng-Yue M; Mullen PJ; Quiroga AD; Wasylishen AR; Clendening JW; Sendorek DH; Haider S; Lehner R; Boutros PC; Penn LZ
Breast Cancer Res Treat; 2014 Jan; 143(2):301-12. PubMed ID: 24337703
[TBL] [Abstract][Full Text] [Related]
12. VEGFA Involves in the Use of Fluvastatin and Zoledronate Against Breast Cancer.
Pu H; Zhang Q; Zhao C; Shi L; Wang Y; Wang J; Zhang M
Pathol Oncol Res; 2018 Jul; 24(3):557-565. PubMed ID: 28744693
[TBL] [Abstract][Full Text] [Related]
13. Fluvastatin inhibits high glucose-induced nuclear factor kappa B activation in renal tubular epithelial cells.
Gao P; Wu X; Shui H; Jia R
J Nephrol; 2013; 26(2):289-96. PubMed ID: 22641573
[TBL] [Abstract][Full Text] [Related]
14. Protection against monocrotaline-induced pulmonary arterial hypertension and caveolin-1 downregulation by fluvastatin in rats.
Zhu S; Wang J; Wang X; Zhao J
Mol Med Rep; 2018 Mar; 17(3):3944-3950. PubMed ID: 29286128
[TBL] [Abstract][Full Text] [Related]
15. Fluvastatin prevents renal injury and expression of lactin-like oxidized low-density lipoprotein receptor-1 in rabbits with hypercholesterolemia.
Yu YH; Wang Y; Dong B; Sun SZ; Chen Y; Meng XH; Liu ZZ
Chin Med J (Engl); 2005 Apr; 118(8):621-6. PubMed ID: 15899115
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria-targeted nitroxides exacerbate fluvastatin-mediated cytostatic and cytotoxic effects in breast cancer cells.
Cheng G; Lopez M; Zielonka J; Hauser AD; Joseph J; McAllister D; Rowe JJ; Sugg SL; Williams CL; Kalyanaraman B
Cancer Biol Ther; 2011 Oct; 12(8):707-17. PubMed ID: 21799303
[TBL] [Abstract][Full Text] [Related]
17. Stimulatory effects of low-dose 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activated protein kinase.
Uruno A; Sugawara A; Kudo M; Satoh F; Saito A; Ito S
Hypertens Res; 2008 Nov; 31(11):2085-96. PubMed ID: 19098381
[TBL] [Abstract][Full Text] [Related]
18. Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration.
Ravid D; Chuderland D; Landsman L; Lavie Y; Reich R; Liscovitch M
Exp Cell Res; 2008 Sep; 314(15):2762-73. PubMed ID: 18598695
[TBL] [Abstract][Full Text] [Related]
19. Role of SGK1 for fatty acid uptake, cell survival and radioresistance of NCI-H460 lung cancer cells exposed to acute or chronic cycling severe hypoxia.
Matschke J; Wiebeck E; Hurst S; Rudner J; Jendrossek V
Radiat Oncol; 2016 Jun; 11():75. PubMed ID: 27251632
[TBL] [Abstract][Full Text] [Related]
20. Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling.
Ravid D; Maor S; Werner H; Liscovitch M
Oncogene; 2005 Feb; 24(8):1338-47. PubMed ID: 15592498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
